Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice
- PMID: 16143432
- DOI: 10.1016/j.vaccine.2005.07.098
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice
Abstract
Avian influenza viruses represent a growing threat for an influenza pandemic. To develop recombinant vaccine for avian influenza of the H9N2 subtype, we expressed in insect cells virus-like particles (VLPs) consisting of three structural proteins of influenza A/Hong Kong/1073/99 (H9N2) virus. Upon infection of Sf9 cells with recombinant baculoviruses, the hemagglutinin (HA), neuraminidase (NA), and matrix (M1) proteins were co-expressed in the infected cells, self-assembled, and released into the culture medium as VLPs of 80-120nm in diameter. VLPs exhibited functional characteristics of influenza virus including hemagglutination and neuraminidase activities. In BALB/c mice, VLPs elicited serum antibodies specific for influenza A/Hong Kong/1073/99 (H9N2) virus and inhibited replication of the influenza virus after challenge. Thus, VLPs represent a potential strategy for the development of human vaccines against avian influenza H9N2 viruses.
Similar articles
-
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.Vaccine. 2007 May 10;25(19):3871-8. doi: 10.1016/j.vaccine.2007.01.106. Epub 2007 Feb 15. Vaccine. 2007. PMID: 17337102
-
Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.Vaccine. 2007 May 22;25(21):4283-90. doi: 10.1016/j.vaccine.2007.02.059. Epub 2007 Mar 9. Vaccine. 2007. PMID: 17403562
-
Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.Biochem Biophys Res Commun. 2006 May 19;343(4):1124-31. doi: 10.1016/j.bbrc.2006.03.088. Epub 2006 Mar 23. Biochem Biophys Res Commun. 2006. PMID: 16580631
-
Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.Jpn J Infect Dis. 2000 Dec;53(6):219-28. Jpn J Infect Dis. 2000. PMID: 11227019 Review.
-
Influenza virus-like particle vaccines.Expert Rev Vaccines. 2009 Apr;8(4):435-45. doi: 10.1586/erv.09.8. Expert Rev Vaccines. 2009. PMID: 19348559 Review.
Cited by
-
Probing Baculovirus Vector Gene Essentiality for Foreign Gene Expression Using a CRISPR-Cas9 System.Methods Mol Biol. 2024;2829:127-156. doi: 10.1007/978-1-0716-3961-0_9. Methods Mol Biol. 2024. PMID: 38951331
-
Scientific barriers to developing vaccines against avian influenza viruses.Nat Rev Immunol. 2007 Apr;7(4):267-78. doi: 10.1038/nri2054. Nat Rev Immunol. 2007. PMID: 17363960 Free PMC article. Review.
-
Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.J Virol. 2008 Dec;82(23):11813-23. doi: 10.1128/JVI.01076-08. Epub 2008 Sep 10. J Virol. 2008. PMID: 18786995 Free PMC article.
-
Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination.J Virol. 2009 May;83(9):4489-97. doi: 10.1128/JVI.02035-08. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211762 Free PMC article.
-
Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development.Viruses. 2020 May 8;12(5):518. doi: 10.3390/v12050518. Viruses. 2020. PMID: 32397182 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical